Chanelle Group, Ireland’s largest indigenous manufacturer of generic pharmaceuticals for human and animal health has recently announced the appointment of Mr. David Kelly, as General
Employing over 375 people in Ireland, the UK and Jordan, the company recently announced a €70m investment which will double existing manufacturing capacity
at its Loughrea headquarters and see significant investment in Research & Development.
Mr. Kelly joins the company from medical device company ArraVasc, where he served as Chief Financial Officer.
He previously served as Head of Finance for Chanelle Group from 2006 to 2008 and has held senior financial management positions in Irish, multinational and publicly quoted
companies including Boston Scientific, Aryzta plc and Aer Rianta International.
David will work closely with Chanelle Group founder Michael Burke, to oversee the company’s investment programme and lead Chanelle’scontinued expansion in Ireland
and overseas markets.
Commenting on David Kelly’s appointment, Michael Burke, founder, Chanelle Group said:
“We have ambitious plans for our company over the next five years, growing our team to over 550 people and expanding into new markets.
Our product pipeline is very strong and with continued investment in R&D we plan to launch 75 new products in both human and veterinary healthcare over the coming years.
David’s extensive industry experience in the healthcare sector as well as his knowledge of Chanelle Group will be invaluable to us as we realise these plans”.
David Kelly said; “This innovation-led company is now exporting to over 80 countries worldwide and is embarking on an expansion programme which will strongly position
the company for future growth. Michael Burke has grown the company to its leading position today and I am delighted to work with Michael and the team as we lead the
company in its next phase of growth”.
Mr. Kelly holds a first class honours degree in Accounting & Finance, a Masters in Business Studies from Dublin City University and a Postgraduate Diploma in
Strategy & Innovation from the Irish Management Institute. He is a Fellow of the Institute of Chartered Accountants in Ireland.